Stocklytics Platform
Asset logo for symbol TMDX
TransMedics Group
TMDX73
$69.16arrow_drop_up1.64%$1.12
Asset logo for symbol TMDX
TMDX73

$69.16

arrow_drop_up1.64%

Income Statement (TMDX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT$3.92M$12.50M$12.42M$7.46M-$25.23M
EBITDA$13.03M$17.10M$16.82M$11.17M-$23.33M
gross Profit$60.84M$69.16M$59.86M$47.92M$40.66M
NET Income$4.21M$12.19M$12.19M$4.03M-$25.42M
total Revenue$108.76M$114.30M$96.85M$81.17M$66.43M

Balance Sheet (TMDX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt$188.05M$153.74M$166.00M$121.13M$88.54M
stockholders Equity$209.92M$189.89M$159.47M$137.20M$126.46M
total Assets$785.57M$758.57M$723.83M$706.04M$689.22M
total Debt$518.14M$516.49M$516.22M$515.94M$515.65M
total Liabilities$575.65M$568.68M$564.36M$568.84M$562.76M

Cash Flow (TMDX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$7.86M$10.64M$3.18M$924.00K$1.52M
free Cash Flow-$41.34M$1.95M-$47.60M-$33.51M-$141.80M
investing Cash Flow-----
operating Cash Flow$6.85M$25.71M-$3.43M$8.30M-$6.86M

TransMedics Group (TMDX) Financials

TransMedics Group Inc (TMDX) is a medical technology company that specializes in developing and commercializing organ transplant solutions. The company's financials provide insights into its performance and financial health. The income statement shows the revenue and expenses generated by the company during a particular period. It includes the gross profit, which represents the revenue minus the cost of goods sold. The net income from stockholders reflects the profit or loss attributable to stockholders after deducting all expenses, taxes, and interest.
TransMedics Group Inc's total revenue represents the combined sales from all its products and services. The company's balance sheet provides a snapshot of its financial position at a specific point in time. It includes the total assets, which represent the resources owned by the company, and the total liabilities, which represent the company's obligations and debts. The stockholders' equity represents the residual interest in the company's assets after deducting liabilities.
TransMedics Group Inc's cash equivalents refer to highly liquid assets that can be readily converted into cash. Net debt is the difference between a company's total debt and its cash and cash equivalents. The financing cash flow shows the cash inflows and outflows related to the company's financing activities, such as issuing or repurchasing stock and paying dividends. The free cash flow represents the cash generated by the company after deducting its capital expenditures. The investing cash flow reflects the cash inflows and outflows related to the company's investments, such as acquiring or selling assets. The operating cash flow represents the cash generated by the company's primary business activities, such as sales and services.
add TransMedics Group  to watchlist

Keep an eye on TransMedics Group

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level